These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19893992)

  • 21. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.
    Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z
    J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis.
    Hass HG; Jobst J; Vogel U; Scheurlen M; Nehls O
    Oncol Res Treat; 2014; 37(12):732-8. PubMed ID: 25531719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status.
    Song MA; Kwee SA; Tiirikainen M; Hernandez BY; Okimoto G; Tsai NC; Wong LL; Yu H
    Epigenetics; 2016 Jun; 11(6):464-74. PubMed ID: 27248055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
    Seshachalam VP; Sekar K; Hui KM
    J Gastroenterol Hepatol; 2018 Dec; 33(12):2037-2047. PubMed ID: 29672926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver.
    Xu XR; Huang J; Xu ZG; Qian BZ; Zhu ZD; Yan Q; Cai T; Zhang X; Xiao HS; Qu J; Liu F; Huang QH; Cheng ZH; Li NG; Du JJ; Hu W; Shen KT; Lu G; Fu G; Zhong M; Xu SH; Gu WY; Huang W; Zhao XT; Hu GX; Gu JR; Chen Z; Han ZG
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15089-94. PubMed ID: 11752456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.
    De Giorgi V; Monaco A; Worchech A; Tornesello M; Izzo F; Buonaguro L; Marincola FM; Wang E; Buonaguro FM
    J Transl Med; 2009 Oct; 7():85. PubMed ID: 19821982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.
    Okabe H; Satoh S; Kato T; Kitahara O; Yanagawa R; Yamaoka Y; Tsunoda T; Furukawa Y; Nakamura Y
    Cancer Res; 2001 Mar; 61(5):2129-37. PubMed ID: 11280777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.
    Tornesello ML; Buonaguro L; Izzo F; Buonaguro FM
    Oncotarget; 2016 May; 7(18):25087-102. PubMed ID: 26943571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
    Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
    Cancer Res; 2002 Jul; 62(14):3939-44. PubMed ID: 12124323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.
    Mas VR; Maluf DG; Archer KJ; Yanek K; Kong X; Kulik L; Freise CE; Olthoff KM; Ghobrial RM; McIver P; Fisher R
    Mol Med; 2009; 15(3-4):85-94. PubMed ID: 19098997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile.
    Tsunedomi R; Iizuka N; Yamada-Okabe H; Tamesa T; Okada T; Sakamoto K; Takashima M; Hamaguchi T; Miyamoto T; Uchimura S; Hamamoto Y; Yamada M; Oka M
    Int J Oncol; 2006 Dec; 29(6):1445-51. PubMed ID: 17088983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
    Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
    J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma.
    Smith MW; Yue ZN; Geiss GK; Sadovnikova NY; Carter VS; Boix L; Lazaro CA; Rosenberg GB; Bumgarner RE; Fausto N; Bruix J; Katze MG
    Cancer Res; 2003 Feb; 63(4):859-64. PubMed ID: 12591738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.